Nice to see our partner highlighting RPE cell therapy. At #AAO2026, #retina specialists heard firsthand about treatments that can make a meaningful difference for #dryAMD patients. $LCTX #OpRegen #ReplaceandRestore @CEO_Culley

$LCTX wishes to thank everyone who participated in the Spinal Cord Injury Patient-Focused Drug Development Meeting, especially individuals living with #SCI and care partners who shared their experiences and perspectives. Several themes came through clearly, including how restoring any kind of function, even incremental improvements, can translate into meaningful changes in everyday activities, personal care and quality of life. @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Join us on September 29 for the @scipfdd Spinal Cord Injury Patient-Focused Drug Development Meeting — a free, virtual event where the SCI community will share their experiences and needs directly with the FDA. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Register now for the free, virtual @scipfdd SCI PFDD Meeting on Sept. 29! Participants will discuss daily life with SCI, experiences with treatments, and priorities for future research. Register: scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Lineage is proud to support the upcoming @scipfdd SCI Patient-Focused Drug Development (PFDD) Meeting on September 29! This free, virtual event brings the experiences of individuals with SCI directly to FDA and treatment developers. scipfdd.org/register @CEO_Culley #SCIPFDD #SCI #PFDD @reevefoundation @CIRMnews @U2FP_CureSCI @ASIA_spine @PVA1946 @NASCIC1 @UnitedSpinal @SCoBIRC

Today, $LCTX announced the issuance of a U.S. Patent covering the company’s proprietary AlloSCOPE™ 5D manufacturing platform. investor.lineagecell.com/new… #CellManufacturing #ReplaceAndRestore

On #WorldSCIDay, all of us at $LCTX would like to recognize decades of collective global effort to raise awareness, strengthen prevention, and advance meaningful action for people living with spinal cord injury. Learn more about World SCI Day: iscos.org.uk/page/SciDay @CEO_Culley | @ISCoSmeetings #CellTherapy #SCI

$LCTX reported second quarter 2026 financial results and will host a conference call at 4:30 pm ET / 1:30 pm PT today to provide a business update. Learn more: bit.ly/4xtq2io @CEO_Culley | #ReplaceAndRestore

$LCTX announced it will report Q2 2026 financial and operating results on Thursday, August 6, 2026. Management will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT to provide a business update. For more: bit.ly/4w0R3IP #ReplaceAndRestore

$LCTX thanks @DDWJournal for featuring @CEO_Culley in its Summer 2026 issue. Brian discusses the potential of cell replacement therapies in ophthalmology, including Lineage’s recently launched and wholly owned COR1 program, and the AlloSCOPE™ platform. bit.ly/4pwHPT7